[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Helios University Hospital Wuppertal\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100628706","an-international-field-study-of-the-reliability-and-validity-of-a-disease-specific-questionnaire-module-the-qlq-ov28-in-assessing-the-quality-of-life-of-patients-with-ovarian-cancer---phase-iii-100628706",false,"NCT07465133","Updating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38)","The Update of the EORTC QLQ-Ovarial Cancer Module (EORTC-QLQ-OV28) - OV39 Phase III","EORTC QLQ-OV39","Inclusion Criteria:\n\n1. Evidence of localized (FIGO I-II) or advanced ovarian cancer (FIGO II-IV)\n2. Must be able and willing to complete the questionnaires.\n3. Must be able to understand and speak the language in which the patient will complete the questionnaire.\n4. Age \\> 18 years\n\nExclusion Criteria:\n\n* cognitive impairment","FEMALE","18 Years",{"count":20,"type":21},50,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to pre-test the EORTC QLQ-OV39 to identify and resolve potential problems in its administration and to identify missing\u002Fredundant items. A preliminary evaluation of the measurement properties of the module will be carried out.\n\nThe study includes patients with evidence of localized (FIGO I-II) or advanced ovarian cancer (FIGO II-IV) above the age of 18 years.\n\nThe main aims are:\n\n1. To conduct Phase 3a and 3b pre-testing of the preliminary EORTC-QLQ-OV39 Questionnaire to identify and resolve potential problems in its administration and to identify missing\u002Fredundant items according to the updated EORTC QLG Guidelines for Module Development, 5th Edition 2021.(16)\n2. a preliminary assessment of the psychometric properties of the module\n\nParticipants will \\[describe the main tasks participants will be asked to, complete the OV39, C30 and debriefing interviews, as well as questions about their demographics and clinical data.",[25,26],"Ovarian Cancer","Quality of Life",[28,29,26,30],"ovarian cancer","EORTC","EORTC Quality of life group","NOT_YET_RECRUITING","2026-09-15",{"date":34,"type":35},"2026-09-18","ACTUAL",{"date":37,"type":21},"2026-09",{"date":39,"type":21},"2028-12",{"name":41,"class":42},"Helios University Hospital Wuppertal","OTHER",""]